glp-1 news today pharma BIG NEWS: 10 Patient Announcements This Week (GLP1, Foundayo, Zepbound, Wegovy news!) A $60 billion industry just

Monitor Symptoms : Record how you feel daily to share with your doctor

These are serious metabolic drugsnot novelty lifestyle accessories

General Practitioners can already refer to any practitioner who is on the Voluntary Accredited Register held by the Professional Standards Authority for Health and Social Care (PSA)

However, the discovery opens up an exciting breakthrough for precision medicine: it suggests that instead of taking a heavy metabolic drug, patients might eventually be able to treat depression directly using targeted, high-potency probiotics containing Lactobacillus delbrueckii to trigger the same stress-reducing gut-brain pathway

Both pathways protect retinal cells (including RGCs) from damage induced by high glucose or ischemic conditions

Thus, it is possible that these data support the idea that peripheral and central GLP1 may act independently as well as additively to suppress food intake (Brierley et al., 2020)